510(k) Report

510(k) · Cleared

Cleared

Healthline Redi-Neb Medication Nebulizer, Model RN-510

K080969510(k) TraditionalCleared Jul 25, 2008112-day reviewClass II21 CFR 868.5630

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Medi Nuclear Corp., Inc. · CAF Nebulizer (Direct Patient Interface)

Cleared on Jul 25, 2008 as substantially equivalent to K915075 (Medi Nuclear Corp., Inc., 1992) and 1 other predicate after a 112-day review. Its family tree reaches back 2 generations to 1987.

Decided
Jul 25, 2008
Review
112 days
Class
Class II
Product code
CAF
Recalls
None
Predicates
2

Its longest line of descent runs back 2 generations to K870027 (1987). 3 ancestors in all. No later device cites it as a predicate yet.

Other ancestors, by year cleared 1992: 1 other ancestorK870027 · Hand Held Pheumatic Powered (Disposable) Nebulizer · Salter Labs · 1987 · recalledK962879 · Salterlabs 8660 Series Nebulizer · Salter Labs · 1996 · recalled198519901995200020052010
Other ancestors, by generation 1 generation back: 1 other ancestor K962879 · Salterlabs 8660 Series Nebulizer · Salter Labs · 1996 · recalledK870027 · Hand Held Pheumatic Powered (Disposable) Nebulizer · Salter Labs · 1987 · recalled0
  1. Root · 2 generations backK870027 Hand Held Pheumatic Powered (Disposable) NebulizerSalter Labs · 1987 · Recalled
  2. 1 generation backK962879 Salterlabs 8660 Series NebulizerSalter Labs · 1996 · Recalled
  3. This deviceK080969 Healthline Redi-Neb Medication Nebulizer, Model RN-510Medi Nuclear Corp., Inc. · 2008
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K870027Hand Held Pheumatic Powered (Disposable) NebulizerSalter Labs19871
−1K962879Salterlabs 8660 Series NebulizerSalter Labs19961
0 (this device)K080969Healthline Redi-Neb Medication Nebulizer, Model RN-510Medi Nuclear Corp., Inc.2008—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199210
FIG. 1 — Lineage of K080969, 1987–2008Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in CAF? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new CAF device

  1. #1 K260270 FindAir ONE for pMDI (FAO-MDI-V12-GRE-001)score 13.3 · 7 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K915075Nebulizer (Direct Patient Interface)
Summary page 1
…Hereinafter referred to as "RediNeb®" 3. PREDICATE DEVICE: We hereby designate the Medi/Nuclear Neb-3A Patient Nebulizer (K915075) and Salter Labs Model 8660 NebuTech HDN Nebulizer (K962879) as predicate devices for the RediNeb®medication Nebulizer…
Medi Nuclear Corp., Inc.1992—
*K962879Salterlabs 8660 Series Nebulizer
Summary page 1
…3. PREDICATE DEVICE: We hereby designate the Medi/Nuclear Neb-3A Patient Nebulizer (K915075) and Salter Labs Model 8660 NebuTech HDN Nebulizer (K962879) as predicate devices for the RediNeb®medication Nebulizer. Medi/Nuclear will manufacture the RediNeb® for its affilia…
Salter Labs19961

Also cleared against K915075: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 21 years and passes through 2 companies; a new generation was cleared every 11.8 years on median.
  • 2 of the 3 ancestors have a recall of any class.
  • 1 other device also cites its predicate K915075.

How does its category compare?

All CAF devices

CAF Nebulizer (Direct Patient Interface): FDA decisions, review times, recalls and adverse event reports over 20 years. 2008, this device’s year, is highlighted.

FDA decisions per year · CAF

7in 2025

2007: 182008: 122009: 82010: 102011: 102012: 92013: 92014: 92015: 82016: 52017: 82018: 92019: 32020: 62021: 82022: 42023: 82024: 42025: 72026 (partial year): 2
2007high 18 (2007) · low 3 (2019)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · CAF

211in 2025

2007: 98 days median2008: 123 days median2009: 163 days median2010: 114 days median2011: 157 days median2012: 126 days median2013: 238 days median2014: 151 days median2015: 186 days median2016: 186 days median2017: 253 days median2018: 161 days median2019: 266 days median2020: 219 days median2021: 324 days median2022: 176 days median2023: 279 days median2024: 251 days median2025: 211 days median
2007high 324 (2021) · low 98 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · CAF

1in 2018

2007: 12011: 12014: 52015: 32016: 12017: 14, 13 Class I2018: 1
2007high 14 (2017) · low 0 (2008)2026

Class I (13 since 2007) Class II/III not classified

Adverse event reports per year · CAF

191in 2025

2007: 262008: 112009: 152010: 372011: 2372012: 1382013: 2172014: 1232015: 1662016: 2012017: 2562018: 1622019: 1852020: 1172021: 1612022: 552023: 1072024: 1022025: 191
2007high 256 (2017) · low 11 (2008)2025

MAUDE reports naming product code CAF, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071898126
200812123011
20098163015
201010114037
2011101571237
201291260138
201392380217
201491515123
201581863166
201651861201
2017825314 (13)256
201891611162
201932660185
202062190117
202183240161
20224176055
202382790107
202442510102
202572110191
20262—0—

What is it indicated for?

The Healthline RediNeb® Small Volume Medication Nebulizer (SVN) is indicated to aerosolize medication approved for nebulization by a physician. The Healthline RediNeb® Medication Nebulizer is intended for adult and pediatric patients consistent with the indications for aerosolized medication to or through the patient's pulmonary system.

The RediNeb® Nebulizer device is for patient use in all areas where the administration of medication by aerosol means is warranted. This includes hospital/institutional settings, home care use, schools and long term care facilities.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K080969: Healthline Redi-Neb Medication Nebulizer, Model RN-510.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 3, 2026. https://510kreport.com/device/K080969

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026